1. Introduction: The Strategic Reclassification of Chronic Wounds
In the realm of advanced wound management, we often find ourselves trapped by a narrow definition of success: “days to healing.” For many patients, particularly those navigating complex multi-system comorbidities or the final stages of life, this curative focus is not only clinically unrealistic but can be unintentionally cruel. As Lead Clinical Nurse Specialists, our role must evolve from “healers” to “patient advocates.”
Strategic reclassification from “healable” to “maintenance” or “nonhealable” is a proactive advocacy for the patient’s dignity. It is a decision made to interrupt the “spiral of hopelessness”—the psychological trauma that occurs when patients and families face repeated healing failures despite aggressive intervention. By pivoting toward symptom optimization and Health-Related Quality of Life (HRQoL), we transition from a mindset of clinical failure to one of person-centered clinical excellence.
——————————————————————————–
2. The “When”: Clinical and Systemic Indicators for Reclassification
Determining the transition to maintenance care requires a rigorous synthesis of cofactors. When these impediments are uncorrectable, the biological trajectory of the wound fundamentally shifts.
Physiological Barriers (Cofactors)
- Oxygenation and Perfusion: Tissues require dissolved oxygen for collagen formation and leukocyte activity.
- The Smoking Triad: While nicotine is a potent vasoconstrictor, the presence of hydrogen cyanide is a critical cellular blockade. It inhibits the enzyme systems necessary for oxidative metabolism and cellular transport of oxygen. In this state, even high-quality local care cannot overcome the cellular-level inability to utilize oxygen.
- Subclinical Hypovolemia: Insufficient intravascular volume hinders nutrient transport. Even supplemental oxygen is ineffective if tissues are poorly perfused; warm, well-perfused patients tolerate fluid volumes that support healing, whereas cold, vasoconstricted patients remain at high risk.
- Metabolic and Nutritional Status: Severe protein-calorie malnutrition delays all phases of repair. Deficiencies in Zinc (collagen formation), Vitamin A (inflammatory response), and Vitamin C (collagen synthesis) can lead to the breakdown of even long-standing, stable wounds.
- Bioburden and Atypical Presentation: Bacteria impose a metabolic load that competes for oxygen. In the elderly, clinicians must look beyond rubor or calor. Infection often presents as a sudden “decreased cognitive function” or a precipitous decline in functional status.
- Old Tissue and the Tolerance to Insult: Chronic wounds are often populated by senescent fibroblasts and stagnant inflammatory cells. While radical debridement is a gold standard for “healable” wounds, in a maintenance scenario, we must weigh the necessity of removing barriers against the patient’s “tolerance to the insult.” If the physiological cost of debridement exceeds the patient’s systemic reserves, the wound must be reclassified.
Systemic Concomitant Conditions
Peripheral Vascular Disease (PVD) creates persistent hypoxia, while Diabetes Mellitus—specifically when glucose levels are poorly controlled—impairs leukocyte function and reduces growth factor receptors. In patients with cancer or those who are otherwise immunocompromised, the body often cannot mount the inflammatory response required to initiate the healing sequence.
——————————————————————————–
3. The “Patient-Goal” Criteria: Using HRQoL as a Primary Metric
When healing is no longer a realistic objective, Health-Related Quality of Life (HRQoL) becomes the clinical gold standard for measuring success.
Symptom Impact on HRQoL
| Physical Symptoms | Psychosocial Impact | Impact on Daily Functioning |
| Pain: Severe, often underestimated. | Identity Loss: The wound dominates the persona. | Sleep Disruption: Due to pain, odor, or drainage. |
| Odor: Putrid, causing gagging/nausea. | Suicidal Thoughts: Linked to depression/shame. | Limited Social Life: Avoidance of public spaces. |
| Exudate: Heavy leakage and skin stripping. | Stigma: Guilt and embarrassment. | Anger, Fear, & Boredom: Related to the “long road.” |
| Pruritus: Intractable itching. | “Life of Fear”: Specifically regarding amputation. | Mobility: Problems with footwear/clothing. |
Comparative and Clinical Gold Standards
To drive reclassification, we utilize two distinct types of Patient-Reported Outcome Measures (PROMs):
- Generic HRQoL Tools (SF-36): The “comparative gold standard.” This is used primarily for administrative resource allocation, allowing us to compare the health state of a wound patient to those with other chronic conditions.
- Condition-Specific Tools (Cardiff Wound Impact Schedule): The “clinical gold standard.” This is more sensitive to granular changes in a maintenance state, tracking how a specific intervention (like odor control) improves the patient’s lived experience.
——————————————————————————–
4. Special Considerations: Skin Failure and SCALE
In palliative contexts, we must differentiate between a localized pressure injury and the physiological failure of the skin as a multi-system organ.
The Unifying Concept of Skin Failure
Skin failure occurs when the skin and underlying tissue die due to hypoperfusion concurrent with severe dysfunction of other organ systems.
- Acute Skin Failure: Associated with critical, acute illness such as septic shock or myocardial infarction (MI).
- Chronic Skin Failure: Occurs alongside chronic, progressive conditions such as multiple sclerosis (MS) or advanced malignancy.
- End-Stage Skin Failure: Occurs as part of the dying process in the setting of terminal renal or pulmonary failure.
SCALE and Terminal Ulcers
Skin Changes At Life’s End (SCALE) describes unavoidable physiological changes during the dying process.
- Kennedy Terminal Ulcer (KTU): A pear-shaped, butterfly, or horseshoe-shaped injury, usually on the sacrum. It appears suddenly and signals impending death, typically within two to six weeks.
- 3:30 Syndrome: A variant of the KTU where the skin is intact in the morning but presents as a blackened, macular patch by 3:30 PM. This signals a life expectancy of only 8 to 24 hours.
- Trombley-Brennan Terminal Tissue Injury (TB-TTI): These present as pink, purple, or maroon bruise-like alterations. They are often characterized by mirror images (appearing symmetrically) and linear striations on the legs.
- Prognostic Detail: 75% of patients with an identified TB-TTI die within 72 hours.
——————————————————————————–
5. The “How”: Implementing the 5 P’s of Intervention
Once a wound is reclassified, the “5 P’s” framework guides our clinical strategy:
- Prevention: Implementing measures to avoid new injuries, even when existing ones are nonhealable.
- Prescription: Targeted treatment for wounds that still retain some localized healing potential.
- Preservation: Focused maintenance to ensure the wound bed does not deteriorate further.
- Palliation: Prioritizing comfort; for example, electing to manage pain during dressing changes rather than performing a radical removal of devitalized tissue.
- Preference: Ensuring every intervention aligns with the patient’s expressed desires and terminal goals.
Management of Nonhealable Wounds: Odor Control
Odor management is a cornerstone of maintenance care.
- Topical Metronidazole (0.75% or 0.8% gel): This is highly effective at eradicating anaerobic bacteria. These anaerobes produce putrescine and cadaverine, the two specific volatile compounds responsible for the classic “ulcer smell” that triggers nausea. Topical application reduces malodor, halts tissue necrosis, and improves wound appearance without the systemic side effects of oral antibiotics.
——————————————————————————–
6. Documentation Changes and Regulatory Implications
Accurate documentation is the clinical shield that justifies why a wound has not healed.
- Comprehensive Assessment: Clearly document the uncorrectable risk factors (smoking-induced hypoxia, terminal status).
- Avoidable vs. Unavoidable: Use CMS and NPUAP standards to demonstrate that the provider evaluated risk and implemented the plan of care, yet the wound progressed due to clinical status.
- MDS 3.0 Coding: Document terminal ulcers (KTU) by their clinical name. According to CMS, if a lesion is correctly identified as a terminal ulcer, it is not coded as a “pressure ulcer,” preventing inaccurate facility penalties.
- Charting by Exception: This is appropriate for SCALE scenarios, but the record must still explicitly reflect the plan of care and the patient’s response to maintain regulatory compliance.
——————————————————————————–
7. Ethical Implications and Partnership in Care
The ultimate diagnostic and ethical test for a specialist is the identification of Pyoderma Gangrenosum (PG). A diagnosis of PG requires a biopsy of the ulcer edge to demonstrate neutrophilic infiltrate. If PG is misdiagnosed as a standard ulcer and treated with aggressive debridement, the resulting pathergy (the inflammatory response to trauma) will cause the wound to expand rapidly and catastrophically.
Furthermore, we must practice Active Listening. Patients often report that their early warning symptoms or psychological distress are ignored by clinicians focused solely on wound measurements. Validating these experiences prevents the patient from feeling ignored or abandoned by the medical system.
——————————————————————————–
8. Conclusion: A Call for Individualized Care
Our mission is to bridge the gap between aggressive curative measures and the reality of the patient’s physiological state. By optimizing the “circle of care,” we ensure that the patient remains the central focus, even when the skin can no longer be repaired.
Practice Pearl: Ethical reclassification is not an abandonment of the wound, but an elevation of the patient’s dignity; we must transition from “closing the gap in the skin” to “closing the gap in the patient’s quality of life.”